The National Fragile X Foundation (NFXF) will host a virtual patient-focused drug development (PFDD) meeting for fragile X syndrome on March 3. To be held from 10 a.m. to 2 p.m. EST, the meeting provides an opportunity for members of the fragile X community to help make sure their experiences, perspectives, needs, and priorities are meaningfully incorporated into the development and review of future therapies. In particular, the NFXF is encouraging patients, siblings, parents, caregivers, and…

You must be logged in to read/download the full post.